Degen vs Injective — how do they compare? Degen trades at Rp23.49 (market cap Rp561,72M, Rp44,81M 24h volume), while Injective trades at Rp84,882 (market cap Rp8,46T, Rp1,37T 24h volume). The key difference: Injective is far larger — about 15060.9× Degen's market cap, and Degen's supply is capped (23,6B / 37B DEGEN (64%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Degen for 14 Days and Injective for 36 Days on average.
| DEGEN | INJ | |
|---|---|---|
Market Cap | Rp561,72M | Rp8,46T |
Volume (24h) | Rp44,81M | Rp1,37T |
Circulating Supply | 23,6B / 37B DEGEN (64%) | 100M INJ |
Typical Hold Time | 14 Days | 36 Days |
Signals from Pluang's Aura AI — not financial advice
DEGEN is currently trading at Rp24.211 with a market cap of Rp575.05M, showing a bullish technical signal overall. The asset exhibits strong support at Rp25 and resistance at Rp27, with moving averages and oscillators leaning positive. With a circulating supply of 23.6M out of 37M tokens (64% circulation), the token has a relatively short average hold time of 14 days, indicating active trading. No major protocol updates or ecosystem developments were reported recently.
The outlook for DEGEN is cautiously optimistic due to bullish technical indicators and stable support levels. Key opportunities include potential breakouts above resistance if trading volume increases. Major risks involve high volatility, limited liquidity, and the absence of recent fundamental developments. Investors should monitor on-chain activity and exchange listings for signs of sustained growth.
Injective (INJ) is trading at Rp86,314 with a market cap of Rp8.6T, showing bullish technical signals from moving averages while oscillators remain neutral. The token is currently positioned between key support at Rp86,075 and resistance at Rp89,928, with an average hold time of 36 days indicating moderate investor patience. Recent technical momentum suggests potential upward movement if it can break through the immediate resistance level.
Overall outlook remains cautiously optimistic with technical strength supporting potential gains, though the neutral oscillator readings suggest consolidation may precede further movement. Key opportunities include the bullish moving average alignment and strong support levels, while risks involve typical crypto volatility and the need for sustained volume to confirm the bullish trend.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Degen was originally created as a reward token for participants in Farcaster's Degen channel. Initially launched as a meme coin, it has since gained a strong community of developers, crypto creators, and enthusiasts. At the time of its launch, 15% of the total supply was airdropped to active members, and there are plans to eventually distribute 70% of the total supply through airdrops.
Read more on DEGEN →Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →